This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GWPH GW Pharmaceuticals (GWPH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About GW Pharmaceuticals Stock (NASDAQ:GWPH) 30 days 90 days 365 days Advanced Chart Get GW Pharmaceuticals alerts:Sign Up Key Stats Today's Range$218.96▼$218.9650-Day Range$216.90▼$219.2852-Week Range$87.07▼$219.57VolumeN/AAverage Volume899,771 shsMarket Capitalization$6.86 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.Read More… Receive GWPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GW Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address GWPH Stock News HeadlinesHere’s where things stand with GWU resident doctors, hospital nurses’ union contract negotiationsMay 29, 2024 | bizjournals.comMelaka: Malaysia’s 2.2-GW Cutting-Edge Combined Cycle Gas Power PlantOctober 14, 2023 | powermag.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.April 24, 2025 | Stansberry Research (Ad)GWPRF Historical DataSeptember 28, 2023 | uk.investing.comGeorge Washington UniversityAugust 17, 2023 | usnews.comChina Approves 106 GW of New Coal-Fired CapacityMarch 9, 2023 | powermag.comWhy Nasdaq-Traded Marijuana Stocks Remain UndervaluedFebruary 19, 2023 | thestreet.comGW Pharmaceuticals PLC (GWPRF)September 25, 2022 | investing.comSee More Headlines GWPH Stock Analysis - Frequently Asked Questions How were GW Pharmaceuticals' earnings last quarter? GW Pharmaceuticals plc (NASDAQ:GWPH) released its quarterly earnings results on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.63) by $0.27. The firm's revenue for the quarter was up 50.7% compared to the same quarter last year. What other stocks do shareholders of GW Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that GW Pharmaceuticals investors own include NVIDIA (NVDA), Canopy Growth (CGC), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Advanced Micro Devices (AMD) and Alibaba Group (BABA). Company Calendar Last Earnings11/03/2020Today4/23/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:GWPH CIK1351288 Webwww.gwpharm.com Phone44-12-2326-6800FaxN/AEmployees1,161Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,020,000.00 Net Margins-11.05% Pretax MarginN/A Return on Equity-7.46% Return on Assets-6.13% Debt Debt-to-Equity Ratio0.01 Current Ratio5.13 Quick Ratio4.31 Sales & Book Value Annual Sales$311.33 million Price / Sales22.05 Cash Flow$0.01 per share Price / Cash Flow18,588.22 Book Value$23.48 per share Price / Book9.33Miscellaneous Outstanding Shares31,349,000Free FloatN/AMarket Cap$6.86 billion OptionableOptionable Beta2.15 Social Links 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:GWPH) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GW Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GW Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GWPH Stock Free GWPH Stock Alerts